Published in IBI on February 5, 2026, by Julie Ann Mayer, PhD
Ann, J., (2026) Optimising Clinical Trials Through Integrated Biomarker and Translational Data Models - Crown Bioscience. https://blog.crownbio.com/optimising-clinical-trials-through-integrated-biomarker-and-translational-data-models
Immunooncology (IO) drug development increasingly depends on understanding human specific immune mechanisms. However, these subtle, highly coordinated…
Read more
In the rapidly evolving landscape of oncology drug discovery, antibody-drug conjugates (ADCs) represent one of the most promising therapeutic modaliti…
Read more
The final stage of drug discovery focuses on translational and clinical support, turning promising preclinical findings into successful human trials. …
Read more